Showing results (441-450 of 1,350) with videos related to
Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|November 14, 2025
Integrating Pharmacogenomic Insights in GLP-1 Receptor Agonist Therapy: Direct GLP1R and ARRB1 Variants and Indirect CYP2D6 Influences in Personalized Obesity ManagementNavodi Sandamini Jayathilaka, Arunodya Vishwanthi Weththasinghe, Nila Ganamurali, et al.Clinical Pharmacology in Drug Development|October 25, 2025
Pharmacokinetics and bioequivalence of two N-acetylcysteine tablets in healthy Chinese volunteers under fasting and fed conditionsXianmiao Yin, Rui Xia, Huan Song, et al.Clinical Pharmacology in Drug Development|August 6, 2025
Evaluation of the Pharmacokinetics, Bioequivalence, and Safety of Two Preparations of 20-mg Trimetazidine in Healthy Chinese SubjectsDongmei Tan, Fucai Zhang, Xihua Fu, et al.Clinical Pharmacology in Drug Development|December 8, 2015
An open-label clinical trial of the effects of age and gender on the pharmacodynamics, pharmacokinetics and safety of the ghrelin receptor agonist anamorelinPhilip T Leese, John M Trang, Robert A Blum, et al.Clinical Pharmacology in Drug Development|August 12, 2017
Relative Bioavailability of Fixed-Dose Combinations of Tamsulosin and Dutasteride: Results From 2 Randomized Trials in Healthy Male VolunteersOlivia Burns, John Zhu, Michael J Manyak, et al.Clinical Pharmacology in Drug Development|May 11, 2016
Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy SubjectsHerbert Struemper, Thomas Murtaugh, Jane Gilbert, et al.Clinical Pharmacology in Drug Development|May 11, 2016
Pharmacokinetics of the Long-Acting Basal Insulin LY2605541 in Subjects With Varying Degrees of Renal FunctionHelle Linnebjerg, Siak Leng Choi, Eric Chen Quin Lam, et al.Clinical Pharmacology in Drug Development|June 17, 2016
Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy VolunteersVeit J Erpenbeck, Eva Vets, Lien Gheyle, et al.Clinical Pharmacology in Drug Development|May 21, 2016
Relative Bioavailability of an Emulsion Formulation for Omega-3-Acid Ethyl Esters Compared to the Commercially Available Formulation: A Randomized, Parallel-Group, Single-Dose Study Followed by Repeat Dosing in Healthy VolunteersElizabeth K Hussey, Samm Portelli, Michael J Fossler, et al.Clinical Pharmacology in Drug Development|May 21, 2016
Relative Bioavailability of Liquid and Tablet Formulations of the Antiparasitic MoxidectinJoan M Korth-Bradley, Virginia Parks, Alain Patat, et al.Pageof 135